CATRENE Programme to Succeed MEDEA+ as European Nanoelectronics R&D Champion

MEDEA+, the EUREKA pan-European Programme for advanced co-operative Research and Development in Microelectronics, today announced details of the new EUREKA programme called CATRENE (Cluster for Application and Technology Research in Europe on NanoElectronics) that will take up the challenge of increasing Europe's strength in micro- and nanoelectronics after the highly successful MEDEA+ programme reaches its conclusion in 2008. A public/private partnership aimed at ensuring the continued development of European expertise in semiconductor technology and applications, CATRENE will build on the success of MEDEA+ and the previous EUREKA programmes JESSI and MEDEA in fostering the continued development of a dynamic European ecosystem with the critical mass necessary to compete at a global level in high technology industries as these move into the era of nanoelectronics.

Since its inception in 2001, MEDEA+ has made significant contributions to establishing and maintaining European leadership in fields ranging from smart card and image sensing technologies to automotive electronics. European IC companies have successfully developed three basic CMOS process generations in a time schedule in line with or even ahead of the global ITRS roadmap. Three European semiconductor companies are ranked amongst the world wide top ten and Europe's semiconductor industry has 10% of the world wide market. European champions with a strong global market position as wafer processing equipment suppliers, lithography tool and infrastructure suppliers as well as substrate and material suppliers have been added to the industrial landscape.

Like MEDEA+, CATRENE embraces all key actors in the value chain - including applications, technology, materials and equipment suppliers - as well as involving industrial companies of all sizes, universities and other research institutions, supported by Public Authorities. In this way CATRENE will benefit from the strong infrastructure for cross-border cooperation that has been developed by MEDEA+ and its predecessors.

An important feature of CATRENE is the concept of Lighthouse Projects, which address major socioeconomic needs such as transportation, healthcare, security, energy and entertainment through focussed R&D programmes. In the foreseeable future, the role of electronics and information systems will further increase as European society is faced with structural problems such as ageing of the population, exploding healthcare cost, transportation bottlenecks, rising energy costs and the need to increase productivity to be competitive on a worldwide basis. These societal challenges are also major opportunities for European industry and are designed to help European companies to address these new lead markets and to become worldwide market leaders. The "umbrella" lighthouse projects will serve as a focus for specific technology and applications development projects that address these challenges.

"For more than a decade, the EUREKA JESSI, MEDEA and MEDEA+ programmes have made it possi-ble for Europe's industry to reinforce its position in semiconductor process technology, manufac-turing and applications, and to become a key supplier to markets such as telecommunications, consumer electronics and automotive electronics", said Jozef Cornu, Chairman of MEDEA+ and designated Chairman of CATRENE. "Nanoelectronics will offer enormous opportunities to those who are the first to master and bring to market new technologies and applications and we believe that CATRENE will play a vital role in helping Europe's microelectronics industry to go from strength to strength."

While the JESSI, MEDEA and MEDEA+ programmes were divided into technology and applications sub-programmes, CATRENE recognises the increasing convergence of technology and applications. It will therefore focus on large identified application markets, deriving from these the roadmap of required technologies. Key technology goals include maintaining and increasing Europe's strength in IP (Intellectual Property) across the entire electronics supply chain and its leadership in lithography and Silicon-on-Insulator materials; ensuring that European companies are among the world leaders in the advanced semiconductor technologies that allow entire systems to be integrated in a single package; and strengthening European expertise in applying a deep knowledge of semiconductor process technology to efficient design for new electronics applications.

For more information on MEDEA+ and CATRENE visit http://www.medeaplus.org.

About MEDEA+
The MEDEA+ programme (2001-2008) comprised 77 projects involving 20,000 person-years and around 450 partner organisations from large companies (38 %), SMEs (37%), institutes and academia (25%). It delivered important innovations in key application areas such as automotive and traffic control, broadband communications, secure society, energy saving and healthcare.

About CATRENE
CATRENE is a four-year programme, starting 1 January 2008 and extendable by another four years. This is in line with the changing landscape of the semiconductor industry as well as the present view on technology evolution and the time span over which most of the major applications will develop. Resources required will be annually around 4,000 person-years, equalling about € 6 billion for the extended programme.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...